The Department of Health - Abu Dhabi has announced the adoption of EDE systems for detecting COVID-19, based on the results of the trial period currently being conducted at entry points to the emirate, selected public facilities in Yas Island, and specific entry and exit points in the Mussafah area.
The Abu Dhabi Government Media Office reported online that "the results of the trial period showed high effectiveness of the EDE systems, as more than 20,000 individuals were tested with this device, achieving 93.5% in sensitivity, which reflects the accuracy of the test in accurately identifying infected individuals, and 83% in specificity, indicating the accuracy of the test in identifying uninfected individuals."
Dr. Jamal Mohammed Al Kaabi, Undersecretary of the Department of Health, stated: "Abu Dhabi has adopted a comprehensive strategy to combat the COVID-19 pandemic based on increased testing, safe entry, vaccination, and continued precautionary measures. The use of EDE devices is part of this strategy and reflects the wise leadership's vision in harnessing modern technology to innovate solutions that turn challenges into opportunities. We are pleased to add these systems, which are manufactured in Abu Dhabi, to the approved means for detecting COVID-19 infection and to offer a new option alongside nasal swab and laser tests, especially since they add a new precautionary layer to create safe areas."
The scanning systems, developed by the Abu Dhabi EDE Research Institute, which is affiliated with the International Holding Company, utilize technical advantages that allow for the detection of the likelihood of COVID-19 infection by measuring electromagnetic waves that change upon the presence of the virus's RNA particles in a person’s body. Consequently, they provide immediate results by scanning potentially infected individuals from a distance without imaging or recording.
